Catherine Elix
Affiliations: | 2021 | Loma Linda University, Loma Linda, United States |
Google:
"Catherine Elix"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Martinez SR, Elix CC, Ochoa PT, et al. (2023) Glucocorticoid Receptor and β-Catenin Interact in Prostate Cancer Cells and Their Co-Inhibition Attenuates Tumorsphere Formation, Stemness, and Docetaxel Resistance. International Journal of Molecular Sciences. 24 |
| Ortiz-Hernandez GL, Sanchez-Hernandez ES, Ochoa PT, et al. (2021) The LEDGF/p75 Integrase Binding Domain Interactome Contributes to the Survival, Clonogenicity, and Tumorsphere Formation of Docetaxel-Resistant Prostate Cancer Cells. Cells. 10 |
| Almahmoud S, Elix CC, Jones JO, et al. (2021) Virtual screening and biological evaluation of PPARγ antagonists as potential anti-prostate cancer agents. Bioorganic & Medicinal Chemistry. 46: 116368 |
| Elix CC, Salgia MM, Otto-Duessel M, et al. (2019) Peroxisome proliferator-activated receptor gamma controls prostate cancer cell growth through AR-dependent and independent mechanisms. The Prostate |
| Salgia MM, Elix CC, Pal SK, et al. (2019) Different roles of peroxisome proliferator-activated receptor gamma isoforms in prostate cancer. American Journal of Clinical and Experimental Urology. 7: 98-109 |
| Elix C, Pal SK, Jones JO. (2017) The role of peroxisome proliferator-activated receptor gamma in prostate cancer. Asian Journal of Andrology |
| Ríos-Colón L, Cajigas-Du Ross CK, Basu A, et al. (2017) Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes. Oncotarget |
| Tew BY, Hong TB, Otto-Duessel M, et al. (2017) Vitamin K epoxide reductase regulation of androgen receptor activity. Oncotarget |
| Rios-Colon L, Sanchez TW, Elix CC, et al. (2016) Abstract B06: Repositioning HIV-based small molecule inhibitors of the stress oncoprotein LEDGF/p75 to overcome prostate cancer resistance to taxane chemotherapy Cancer Epidemiology, Biomarkers & Prevention. 25 |
| Colon LR, Elix C, Alicea I, et al. (2015) Abstract 5411: Repositioning HIV-based small molecule inhibitors of the stress survival oncoprotein LEDGF/p75 to overcome taxane resistance in prostate cancer Cancer Research. 75: 5411-5411 |